![]() |
市場調査レポート
商品コード
1701013
フローサイトメトリー市場規模、シェア、成長分析、技術別、製品別、用途別、エンドユーザー別、地域別-2025~2032年産業予測Flow Cytometry Market Size, Share, Growth Analysis, By Technology, By Product, By Application, By End User, By Region - Industry Forecast 2025-2032 |
||||||
|
フローサイトメトリー市場規模、シェア、成長分析、技術別、製品別、用途別、エンドユーザー別、地域別-2025~2032年産業予測 |
出版日: 2025年04月02日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
フローサイトメトリーの世界市場規模は2023年に61億米ドルと評価され、2024年の66億9,000万米ドルから2032年には139億2,000万米ドルに成長し、予測期間(2025~2032年)のCAGRは9.6%で成長する展望です。
フローサイトメトリー市場は、がん、免疫疾患、感染症の罹患率の増加により、大きな成長が見込まれています。バイオテクノロジー、ライフサイエンス、バイオ医薬品セグメントへの研究開発投資の増加が、フローサイトメトリー機器の需要を促進しています。ポイントオブケア(POC)検査用のマイクロ流体フローサイトメトリーの出現などの技術の進歩は、これらの機器の分析能力を高めています。例えば、これらの革新的な検査はフローサイトメトリーを利用して、COVID-19抗原に対する患者の反応に関する重要な洞察を提供し、十分な情報に基づいた治療方針の決定を容易にしています。感染症の流行が世界的に増加し続ける中、フローサイトメトリー技術の採用は拡大し、今後数年間の産業の勢いにさらに貢献すると予想されます。
Global Flow Cytometry Market size was valued at USD 6.1 billion in 2023 and is poised to grow from USD 6.69 billion in 2024 to USD 13.92 billion by 2032, growing at a CAGR of 9.6% during the forecast period (2025-2032).
The flow cytometry market is poised for significant growth, driven by the increasing incidence of cancer, immune disorders, and infectious diseases. Rising R&D investments in biotechnology, life sciences, and biopharmaceutical sectors are fueling the demand for flow cytometry instruments. Technological advancements, such as the emergence of microfluidic flow cytometry for Point-of-Care (POC) testing, are enhancing the analytical capabilities of these instruments. For instance, these innovative tests utilize flow cytometry to provide critical insights into patients' responses to COVID-19 antigens, facilitating informed treatment decisions. As the prevalence of infectious diseases continues to rise globally, the adoption of flow cytometry techniques is expected to expand, further contributing to industry momentum in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Flow Cytometry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Flow Cytometry Market Segments Analysis
Global Flow Cytometry Market is segmented by Technology, Product, Application, End User and region. Based on Technology, the market is segmented into Cell-Based Flow Cytometry and Bead-Based Flow Cytometry. Based on Product, the market is segmented into Reagents & Consumables, Instruments, Services, Software and Accessories. Based on Application, the market is segmented into Research Applications, Clinical Applications and Industrial Applications. Based on End User, the market is segmented into Academic & Research Institutes, Hospitals & Clinical Testing Laboratories and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Flow Cytometry Market
The rising focus on personalized medicine and targeted therapies is significantly boosting the demand for advanced flow cytometry techniques. Flow cytometry's capability to simultaneously analyze multiple parameters enhances the precise characterization of cells, which is essential in formulating individualized treatment strategies. This technology allows for a deeper understanding of cellular properties and behaviors, making it an invaluable tool in the development of tailored therapeutic approaches. As healthcare increasingly prioritizes personalized treatment options, the role of flow cytometry in accurately assessing and monitoring patient conditions will continue to expand, thereby driving growth in the market.
Restraints in the Flow Cytometry Market
The flow cytometry market faces significant constraints due to the high initial investment and ongoing maintenance costs associated with the equipment. These financial barriers can be a deterrent for many laboratories and institutions, particularly smaller or underfunded facilities that may struggle to allocate sufficient resources for such advanced technology. As a result, the reluctance or inability to invest in flow cytometry can hinder its adoption and integration into various research and clinical settings. Consequently, this financial challenge may limit the overall growth potential of the flow cytometry market, impacting its accessibility and utilization across the healthcare and research sectors.
Market Trends of the Flow Cytometry Market
The flow cytometry market is witnessing a transformative phase, significantly influenced by advancements in cell sorting technologies that enhance the ability to isolate and analyze individual cell populations. This is particularly impactful in critical fields such as cancer research, immunology, and stem cell research, where high purity and accuracy are paramount. The increasing demand for precise cellular analysis in both research and clinical environments is propelling market growth, highlighting the pivotal role of flow cytometry in personalized medicine and targeted therapies. As researchers and clinicians seek innovative solutions to unravel complex cellular behaviors, the flow cytometry market is poised for sustained expansion and innovation.